LCS
PFE icon

Levin Capital Strategies’s Pfizer PFE Stock Holding History

Levin Capital Strategies’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,000
Closed -$398K – 215
2024
Q4 		$398K Buy
+15,000
New +$407K 0.04% 146
2024
Q1 		– Sell
-4,000
Closed -$115K – 276
2023
Q4 		$115K Buy
+4,000
New +$121K 0.01% 229
2022
Q3 		– Sell
-20,000
Closed -$1.05M – 276
2022
Q2 		$1.05M Buy
20,000
+15,000
+300% +$764K 0.12% 88
2022
Q1 		$259K Buy
+5,000
New +$259K 0.03% 229
2021
Q3 		– Sell
-15,000
Closed -$587K – 392
2021
Q2 		$587K Buy
15,000
+5,000
+50% +$194K 0.06% 144
2021
Q1 		$362K Buy
+10,000
New +$355K 0.04% 180

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Levin Capital Strategies's PFE Position: Q3 2025 in Review

Levin Capital Strategies sold out of Pfizer (PFE) in Q3 2025, closing a stake of 14,699 shares — an estimated $356K sold.

Levin Capital Strategies first reported a position in PFE in Q2 2013 and held it in 49 quarters. The position peaked at $368M in Q3 2017. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Levin Capital Strategies reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Levin Capital Strategies sold 14,699 Pfizer shares in Q3 2025, an estimated $356K.
  • Levin Capital Strategies first reported a position in Pfizer in Q2 2013 and held it in 49 quarters.
  • Levin Capital Strategies's Pfizer position peaked at $368M in Q3 2017.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Levin Capital Strategies's 13F filing for Q3 2025, filed 7 Nov 2025.